Expanding Testing Portfolio empowerDX has continuously expanded its testing offerings, including launching specialized tests such as the Celiac Risk Gene Test and PFAS Exposure in 2022, indicating opportunities to offer diverse health testing solutions to healthcare providers, organizations, and consumers seeking comprehensive at-home testing options.

Growing Consumer Reach With successful distribution of COVID-19 home collection kits through platforms like Amazon and government-approved EUA tests, empowerDX demonstrates a capable distribution network that can be leveraged to reach a broader customer base across the United States for various health testing kits.

Private Label Opportunities empowerDX's ability to provide custom groupings of tests and wholesale kits positions it well for partnerships with clinics, health systems, or corporate clients looking to white-label or bulk purchase reliable at-home testing solutions.

Focus on Innovation Recent launches of advanced tests such as PFAS chemical exposure assessment suggest a commitment to innovation and niche health areas, creating opportunities to target specialized healthcare providers and environmental health agencies.

Market Expansion Potential Although current revenue remains below $1 million, the company's strategic product launches and technological infrastructure point to significant growth potential in the expanding at-home health testing market, appealing to enterprise clients and health-focused organizations seeking reliable remote testing services.